Pharmaceuticals & Therapeutics

Midwest Technical Institute awards $305k to students, championing hands-on skills as a secure future in a job market increasingly shaped by AI.

Alaunos Therapeutics reports positive preclinical data for its oral metabolic drug, but with a perilous financial runway, the race for survival is on.

P+Ex appoints industry veteran Dr. Lesley Ko as Executive Director to lead the charge in making concrete preservation a cornerstone of global infrastructure.

Hong Kong's PolyU is leading a global charge, uniting scientists and masters to prove the medical power of Tai Chi and Qigong.

Beneath the roar of engines in Xinjiang's desert lies a story of national ambition, geopolitical strategy, and a state-owned giant's push for dominance.

New data reveals TARA-002 has a 55% complete response rate at one year for NMIBC, offering a promising, safer alternative to standard care.

Pharma veteran Shyamakant Giri takes the helm at Apothecon Group, signaling an aggressive push into global regulated markets backed by Everstone Capital.

Amid major Medicare policy shifts, Nuo Therapeutics reports a 169% revenue surge, positioning its Aurix wound care system as a key market disruptor.

A new study finds a minimally invasive procedure provides greater short-term weight loss than a popular pill, reshaping the debate on obesity treatment.

As its CFO presents at a top NYC conference, Healios K.K. advances novel stem cell treatments for ARDS, stroke, and cancer into critical global trials.

The biotech firm is set to launch its first commercial products, using an innovative strategy to tackle long-neglected markets in women's healthcare.

A new joint venture merges Arna's innovation with Slate Run's market muscle, launching a key diagnostic and targeting high-value specialty medicines.

A key workshop aims to bridge the gap between FDA policy and patient needs, seeking to streamline therapy development for millions with rare diseases.

Soaring costs and long waits at home are driving thousands of Europeans to Albania for dental implants, where clinics offer top-tier care for less.

A new report reveals a startling trend: fewer recall events are leading to a massive 27% surge in recalled units, signaling larger, more dangerous defects.

Senti Biosciences advances its AML cell therapy to a registrational trial after FDA meeting and a key discovery that quadruples patient response rates.

With a new CFO known for big-ticket financing and IPO readiness, clinical-stage OnCusp Therapeutics is gearing up for its next major growth spurt.

A new pill-only combination drug for acute myeloid leukemia promises to reduce hospital visits and improve quality of life for elderly and unfit patients.

METiS TechBio's stock surged over 170% on its debut, as investors bet big on its AI-powered platform to build the future of precision drug delivery.

A new campaign is challenging perceptions of Alzheimer's, but it's fueled by more than stories. It's a nexus of new drugs, blood tests, and patient advocacy.